UNSPSC 51152114: Hyoscyamine/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA802. This VA Drug Class (GA802) classifies this compound as belonging to the group ANTIMUSCARINIC/ANTIPASMODIC COMBINATIONS.

UNSPSC 51152114 Hyoscyamine/phenobarbital is a Commodity code that in recent state and local procurement activity covers the sourcing of naloxone, safe drug deactivation systems, and related pharmaceutical products and services for public health and community safety initiatives. The code appears in solicitations from county health departments and state health and human services agencies focused on emergency response capabilities, substance abuse treatment support, and pharmacy benefit program modernization. The issuing bodies include county-level health authorities and state health agencies operating their own procurement processes independent of federal pharmaceutical contracting vehicles.

Recent activity centers in Florida and Texas. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building and an initial two-year contract term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs and therapeutic pharmacy initiatives, signaling preliminary state interest in restructuring pharmacy benefit delivery outside traditional pharmacy benefit manager and group purchasing organization channels. Both solicitations demonstrate active state and local demand for pharmaceutical supply chain solutions and emergency response products, though the RFI represents exploratory procurement planning rather than an immediate award opportunity.